Anemia, a condition characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, presents a diagnostic challenge due to its diverse etiologies and clinical presentations. This article aims to provide a comprehensive guide to the diagnostic approach for anemia in clinical practice.
A thorough patient history and physical examination provide vital clues to the potential cause of anemia. A detailed dietary history, family history of hematological disorders, and inquiries about symptoms like fatigue, pallor, and dyspnea are essential. Physical examination should include assessment for jaundice, pallor, and signs of underlying systemic diseases.
Initial laboratory investigations should include complete blood count (CBC) and reticulocyte count. The mean corpuscular volume (MCV) can categorize anemia into microcytic, normocytic, or macrocytic, guiding further investigations. Reticulocyte count helps differentiate between underproduction and increased destruction or loss of red blood cells. Additional tests like iron studies, vitamin B12, and folate levels are guided by these results.
When basic investigations do not provide a clear etiology, advanced diagnostic tools can be employed. Bone marrow biopsy can be considered in cases of unexplained normocytic or macrocytic anemia. Hemoglobin electrophoresis is useful in suspected cases of hemoglobinopathies. Genetic testing can also be considered in certain cases.
Anemia is a complex disorder with multiple potential etiologies. A systematic approach to diagnosis, beginning with a detailed history and physical examination, followed by targeted laboratory investigations and, if necessary, advanced diagnostic tools, can help clinicians accurately diagnose and manage this condition. Continuous research and advancements in diagnostic modalities promise to further enhance our understanding and management of anemia.
1.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
2.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
3.
Implant-based reconstruction linked to increased risk of breast lymphomas
4.
Adult overdose deaths on the rise
5.
Simpler Screening Criteria Could Catch More Lung Cancers
1.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Patient Management for Bone Marrow Functional Recovery Pathways
4.
Engineered Red Blood Cell Therapeutics: Emerging Applications
5.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation